Beyond Air, Inc.
XAIR · XNASCIK 1641631fmd_1908C632J9KVSWGJ46KS4EWWW3制造业 · 外科及医疗器械模板: 标准
覆盖范围: 2015年4月02日 至 2026年9月30日，共 43 个期间
| 项目 | FY2018 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | – | – | 8 | 1 | 1 | – | – | 1 | 4 | 8 |
| 利息收入合计 | – | – | – | – | – | – | – | – | 1 | 0 |
| 净利息收入 | 7 | – | – | – | – | – | – | – | (2) | (3) |
| 营业成本 | – | – | – | – | – | – | 1 | 2 | 5 | 7 |
| 毛利润 | – | – | – | – | – | – | (1) | (1) | (2) | 0 |
| 研发费用 | (4) | – | 4 | 11 | 13 | 12 | 17 | 24 | 17 | 10 |
| 销售、一般及管理费用 | – | – | – | – | – | – | – | 37 | 26 | 19 |
| 营业费用合计 | – | – | – | – | – | 41 | 52 | 62 | 43 | 29 |
| 营业利润 | 11 | – | (3) | (18) | (22) | (41) | (52) | (63) | (45) | (29) |
| 利息费用 | – | – | 0 | 0 | 1 | 1 | 0 | 3 | 3 | 4 |
| 利息及投资收益 | – | – | – | – | – | – | – | 2 | 1 | – |
| 其他营业外收入（支出） | – | (1) | (3) | (2) | (1) | (3) | (7) | (1) | (4) | (5) |
| 税前利润 | 18 | – | (7) | (20) | (23) | (44) | (59) | (64) | (48) | (34) |
| 所得税费用 | – | – | – | (0) | – | – | – | – | – | – |
| 持续经营净利润 | – | – | – | (20) | – | – | – | – | – | – |
| 净利润 | (18) | – | (7) | (20) | (23) | (43) | (56) | (60) | (47) | (33) |
| 归属于普通股股东的净利润 | (18) | – | (7) | (20) | (23) | – | – | – | – | – |